Printer Friendly

United States : Goodwin Procter Advises Underwriters in Argos Therapeutics Initial Public Offering.

A team of Goodwin Procter attorneys recently advised the underwriters in the Argos Therapeutics, Inc. initial public offering. The underwriting syndicate was led by Piper Jaffray & Co., Stifel, Nicolaus & Company and JMP Securities LLC. Needham & Company, LLC acted as co-manager.

Shares of Argos Therapeutics priced at $8.00 per share and began trading on the NASDAQ Global Market on February 7, 2014 under the symbol ARGS. The offering initially sold 5,625,000 shares of common stock, and, on February 28, 2014, the underwriters purchased an additional 603,725 shares pursuant to the overallotment option granted to them by the company.

Argos Therapeutics, co-founded by Nobel Prize winner Dr. Ralph Steinman, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis technology platform. The company is based in Durham, N.C.

The Goodwin team advising the underwriters was led by partner Edward King and included partner Michael Maline and associates Caitlin Murray and Courtney Gaughan. Counsel Vivian Pratt (regulatory), partners Duncan Greenhalgh and Brian Fairchild and senior attorney Crystal Komm (IP), and law clerk Duncan Enista provided additional support.

2014 Al Bawaba (Albawaba.com) Provided by Syndigate.info , an Albawaba.com company
COPYRIGHT 2014 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Mar 18, 2014
Words:208
Previous Article:United States : Fairchild Launches A New Brand, Symbolizing A Major Company Transformation.
Next Article:United States : Multi Touch Panel PC Is Available With Android, Windows CE, Or Linux.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters